Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B4997b0bd982bc6c385046e8b5b584c9b> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B4997b0bd982bc6c385046e8b5b584c9b NCIT_P378 "NCI" @default.
- B4997b0bd982bc6c385046e8b5b584c9b type Axiom @default.
- B4997b0bd982bc6c385046e8b5b584c9b annotatedProperty IAO_0000115 @default.
- B4997b0bd982bc6c385046e8b5b584c9b annotatedSource NCIT_C66507 @default.
- B4997b0bd982bc6c385046e8b5b584c9b annotatedTarget "An orally available, piperazine derivative with anti-anginal and potential antineoplastic activities. Ranolazine's mechanism of action for its anti-ischemic effects has yet to be fully elucidated but may involve the alteration of the trans-cellular late sodium current in the ischemic myocyte. By preventing the rise of intracellular sodium levels, ranolazine may affect the transport activity of sodium-dependent calcium channels and prevent the calcium overload during myocardial ischemia, thereby preventing cellular injury. Ranolazine's potential antineoplastic effect may depend on its inhibitory effect on fatty acid oxidation, which may sensitize tumor cells to apoptosis and decrease tumor cell proliferation; fatty acid oxidation provides energy and promotes tumor cell proliferation and survival." @default.